Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview

TRACON Pharmaceuticals

07/05/2024 02:06

* TRACON Pharmaceuticals Inc  TCON.OQ   TCON.O  is expected
to show no change in quarterly revenue when it reports 
results on May 8 (estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for TRACON Pharmaceuticals
Inc is
for a loss of $1.19 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $37.50​, above​ its last closing price
of $1.81. ​​​

This summary was machine generated May 7 at 01:06 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)